Literature DB >> 18722492

Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program.

Angelique G S C Jansen1, Elisabeth A M Sanders, Kristin L Nichol, Anton M van Loon, Arno W Hoes, Eelko Hak.   

Abstract

With a retrospective nationwide cohort study in the Netherlands over 1992-2003, using mortality and viral surveillance data, the aim was to assess by means of rate difference methods the influenza-associated mortality in the elderly before and after the introduction of a nationwide influenza vaccination program in 1996 (vaccination coverage raised from below 50 to 80%). The average annual influenza-associated mortality declined in the years before and after the introduction from 131 to 105 per 100,000 persons (relative risk 0.80). The decline was largest in the age group 65-69 years (relative risk 0.54) and less in those aged 75 years and older. Validation by Serfling-type regression analysis revealed similar results. In conclusion, routine influenza vaccination among Dutch elderly was associated with a significant decrease in influenza-associated mortality, notably in those aged 65-69 years.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18722492     DOI: 10.1016/j.vaccine.2008.08.003

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

1.  Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.

Authors:  Adrian J Reber; Tatiana Chirkova; Jin Hyang Kim; Weiping Cao; Renata Biber; David K Shay; Suryaprakash Sambhara
Journal:  Aging Dis       Date:  2011-09-30       Impact factor: 6.745

Review 2.  The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines.

Authors:  Janet E McElhaney; Xin Zhou; H Keipp Talbot; Ernst Soethout; R Chris Bleackley; David J Granville; Graham Pawelec
Journal:  Vaccine       Date:  2012-01-27       Impact factor: 3.641

3.  [Influenza: special aspects in old age].

Authors:  A Kwetkat; A Leischker; H J Heppner
Journal:  Z Gerontol Geriatr       Date:  2018-06-27       Impact factor: 1.281

4.  Possible hidden hazards of mass vaccination against new influenza A/H1N1: have the cardiovascular risks been adequately weighed?

Authors:  Sucharit Bhakdi; Karl Lackner; Hans-Wilhelm Doerr
Journal:  Med Microbiol Immunol       Date:  2009-11       Impact factor: 3.402

5.  Research priorities for high-quality geriatric emergency care: medication management, screening, and prevention and functional assessment.

Authors:  Christopher R Carpenter; Kennon Heard; Scott Wilber; Adit A Ginde; Kirk Stiffler; Lowell W Gerson; Neal S Wenger; Douglas K Miller
Journal:  Acad Emerg Med       Date:  2011-06       Impact factor: 3.451

Review 6.  Influenza vaccine responses in older adults.

Authors:  Janet E McElhaney
Journal:  Ageing Res Rev       Date:  2010-11-03       Impact factor: 10.895

Review 7.  [Vaccination in advanced age].

Authors:  H J Heppner; A Leischker; P Wutzler; A Kwetkat
Journal:  Internist (Berl)       Date:  2018-02       Impact factor: 0.743

Review 8.  Interventions to increase influenza vaccination rates of those 60 years and older in the community.

Authors:  Roger E Thomas; Diane L Lorenzetti
Journal:  Cochrane Database Syst Rev       Date:  2014-07-07

9.  Trends in Influenza Vaccine Uptake and Severe Influenza-Related Outcomes at Kaiser Permanente Southern California, 2007-2017.

Authors:  In-Lu Amy Liu; Hilary C Tanenbaum; Lei Qian; Lina S Sy; Wansu Chen; Steven J Jacobsen
Journal:  Perm J       Date:  2021-05

Review 10.  Social determinants of health and seasonal influenza vaccination in adults ≥65 years: a systematic review of qualitative and quantitative data.

Authors:  Jason M Nagata; Isabel Hernández-Ramos; Anand Sivasankara Kurup; Daniel Albrecht; Claudia Vivas-Torrealba; Carlos Franco-Paredes
Journal:  BMC Public Health       Date:  2013-04-25       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.